Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy
ClinicalTrials.gov study NCT05379738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
ClinicalTrials.gov study NCT06378060. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01675102. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacroli
ClinicalTrials.gov study NCT05256537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients
ClinicalTrials.gov study NCT05947864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
ClinicalTrials.gov study NCT03964506. IPD Sharing: YES. Countries: 1. Publications: 0.
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01483274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
ClinicalTrials.gov study NCT04184505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
ClinicalTrials.gov study NCT02098512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19
ClinicalTrials.gov study NCT04349540. IPD Sharing: NO. Countries: 1. Publications: 0.
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT02308280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02117115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04375579. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT05471661. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06197672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT02512497. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients
ClinicalTrials.gov study NCT03690115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT03836690. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
ClinicalTrials.gov study NCT06918834. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT03343600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.